nicardipine has been researched along with baclofen in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kostowski, W; Pałejko, W; Plaznik, A; Stefański, R | 1 |
Fields, AM; Hoover, JM; Ibrahim, IN; Kaye, AD; Richards, TA | 2 |
1 review(s) available for nicardipine and baclofen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for nicardipine and baclofen
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Myorelaxant effect of baclofen injected to the nucleus accumbens septi.
Topics: Animals; Baclofen; Behavior, Animal; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Haloperidol; Injections, Intraperitoneal; Male; Microinjections; Midazolam; Muscimol; Muscle Relaxation; Nicardipine; Nucleus Accumbens; Rats; Rats, Inbred Strains; Task Performance and Analysis | 1990 |
Analysis of responses to St. John's Wort in the feline pulmonary vascular bed.
Topics: Acetylcholine; Animals; Arachidonic Acid; Baclofen; Bicuculline; Bradykinin; Calcium Channel Agonists; Cats; Dose-Response Relationship, Drug; Female; GABA Antagonists; Hypericum; Male; Meclofenamic Acid; Muscimol; Nicardipine; Nitric Oxide Donors; Organophosphorus Compounds; Ornithine; Pinacidil; Plant Extracts; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Vasodilator Agents | 2004 |
Analysis of responses to kava kava in the feline pulmonary vascular bed.
Topics: Animals; Baclofen; Bicuculline; Blood Pressure; Bradykinin; Calcium Channel Blockers; Calcium Channels; Cats; Cyclooxygenase Inhibitors; Enzyme Inhibitors; GABA Agonists; GABA Antagonists; Kava; Lung; Meclofenamic Acid; Muscimol; Nicardipine; Nitric Oxide Synthase; Organophosphorus Compounds; Ornithine; Pinacidil; Plant Extracts; Receptors, GABA; Vasodilator Agents | 2006 |